AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
Michael Roth
Public Documents
3
June 16, 2022
Mini-Hyper CVD+CRIB (Condensed Rituximab, Inotuzumab Ozogamicin, and Blinatumomab) fo...
David McCall, Elias Jabbour, Michael Roth, et al.
September 25, 2021
Programmed cell death protein blockade with pembrolizumab for classical Hodgkin lymph...
Irtiza Sheikh, David McCall, Cesar Nunez, et al.
May 18, 2020
Prognostic and Therapeutic Utility of Variably Expressed Cell Surface Receptors in Os...
Yoav Zvi, Elif Ugur, Brian Batko, et al.
